Trial
NCT02365584
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Intestinal Obstruction
Intervention
lanreotide (Autogel formulation)
Why stopped
The study was terminated early due to insufficient recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-22